1st Immunogenicity – Determinants and Correlates Conference

The 1st Immunogenicity – Determinants and Correlates Conference  is a non-commercial meeting sponsored by the Institute for Immunology and Informatics (iCubed) at the University of Rhode Island.  The conference is organized by individuals from a wide range of backgrounds including industry, academics and regulatory agencies such as the FDA, EMEA and NIHS (Japan).

The goal of this meeting is to provide an opportunity to discuss the drivers of immunogenicity and the application of scientific research to improving protein therapeutics and vaccines. The meeting will also bring together vaccine experts, immunologists and protein therapeutics developers for discussion of the latest determinants, correlates and models for predicting immunogenicity.

May 9, 10 and 11
1st Immunogenicity – Determinates and Correlates Conference
Providence, RI

Click here to see the preliminary agenda.

Annie De Groot, University of Rhode Island
Advisory Board
Eric Furfine
Terry Goletz, Amgen
Chris Bailey-Kellogg, Dartmouth
Leslie Cousens, EpiVax Inc.
Daniela Verthelyi, FDA
Eric Wakshull, Genentech
Sara Brett, GlaxoSmithKline
Bonita Rup, Pfizer
Michael Brehm, UMass
David Scott, Uniformed Services University of Health Sciences
Anish Suri, Bristol Myers Squibb
Nick Marsh, Adnexus
Andy Glasebrook, Eli Lilly
Dale Greiner, UMass
Amy Rosenberg, FDA
Naren Chirmule, Amgen
Michel Awwad, Pfizer
Denice Spero, University of Rhode Island
Alan Rothman, University of Massachusetts

Preliminary Agenda

Session I:   Determinants – Predicting Immunogenicity
Session Chair and Panel Leaders: Bonnie Rup, Pfizer and Terry Goletz, Amgen

Session II: Correlates – Biomarkers and Model Systems
Session Chair and Panel Leaders: Michel Brehm, UMass and David Scott, USUHS

Session III: Risk Mitigation – Preclinical Studies and Clinical Studies
Session Chair and Panel Leaders: Eric Furfine and Naren Chirmule, Amgen

Session IV: Case Studies

To be held in conjunction with the TRIAD Toolkit and Tregitope Meeting May 11th.

Please contact Karen Sorrento: karen.l.sorrento@gmail.com

Click here to register!

Click here for hotel accommodations!

Please contact Patrick Lowney with any questions:  plowney.uri@gmail.com

Abstracts due March 15
Please submit abstracts as a word document to Patrick Lowney: plowney.uri@gmail.com

Authors of selected abstracts will be notified by April 1.


  • April 15, 2016

    ISV & Vaccine Renaissance Conference – CALL FOR ABSTRACTS!

    The 2016 ISV Annual Congress in collaboration with Vaccine Renaissance X and DNA Vaccine will be held in Boston, Massachusetts, United States on Oct. 2-4, 2016.    Registration abstract is opening soon! The planning committee encourages you to submit an abstract for consideration! Abstract Submission Deadline: June 24th Abstract Decision Deadline: July 15th   http://www.isvcongress.org/
  • March 11, 2016

    10th Annual Vaccine Renaissance Save the Date Postcard

    CLICK HERE to see the save the date postcard for 2016 ISV Conference
  • February 19, 2016

    iCubed Team Members Making Moves

    This past week at iCubed, Dr. Barbara Lohman Payne received a new title of Associate Research Professor. Barbara joined iCubed and URI as a Research Assistant Professor in 2013, with the Laboratory of Viral Immunity and Pathogenesis. Dr. Lohman-Payne’s area of research is viral immunopathology, with special interest in the impact of HIV exposure in ...